Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.

Oncotarget · 2011 · PMC3248211 · PMID 21865609

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

There was a highly significant difference between patients' protein levels when comparing normal adjacent mucosa with the levels expressed in tumor cells for both Aurora-A and EGFR (Figure 2A ), with independent expression of EGFR and Aurora-A for each patient (r = 0.03 / p = 0.74).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.